CD82 and neoplasm: The authors further demonstrated that the inhibition of the proliferation and invasion of SUM149 and SUM190 breast cancer cells by RhoC knockdown was via the increase of KAI1 (a tumor metastasis suppressor) and decrease of CXCR4 (a tumor progression promoter) and MMP9 [224].